Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
01 Aug 2021
Historique:
received: 28 12 2020
revised: 01 06 2021
accepted: 02 06 2021
pubmed: 13 6 2021
medline: 4 8 2021
entrez: 12 6 2021
Statut: ppublish

Résumé

COVID-19 caused by SARS-CoV-2 corona virus has become a global pandemic. In the absence of drugs and vaccine, and premises of time, efforts and cost required for their development, natural resources such as herbs are anticipated to provide some help and may also offer a promising resource for drug development. Here, we have investigated the therapeutic prospective of Ashwagandha for the COVID-19 pandemic. Nine withanolides were tested in silico for their potential to target and inhibit (i) cell surface receptor protein (TMPRSS2) that is required for entry of virus to host cells and (ii) viral protein (the main protease M

Identifiants

pubmed: 34118289
pii: S0141-8130(21)01215-0
doi: 10.1016/j.ijbiomac.2021.06.015
pmc: PMC8188803
pii:
doi:

Substances chimiques

Antiviral Agents 0
Plant Extracts 0
Viral Matrix Proteins 0
Withanolides 0
membrane protein, SARS-CoV-2 0
Serine Endopeptidases EC 3.4.21.-
TMPRSS2 protein, human EC 3.4.21.-
Ashwagandha V038D626IF

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

297-312

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Jaspreet Kaur Dhanjal (JK)

Indraprastha Institute of Information Technology Delhi, Okhla Industrial Estate, Phase III, New Delhi 110 020, India. Electronic address: jaspreet@iiitd.ac.in.

Vipul Kumar (V)

DAILAB, Department of Biochemical Engineering & Biotechnology, Indian Institute of Technology (IIT) Delhi, Hauz Khas, New Delhi 110 016, India. Electronic address: vipul.kumar@dbeb.iitd.ac.in.

Sukant Garg (S)

AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305 8565, Japan. Electronic address: sukant.garg@aist.go.jp.

Chandru Subramani (C)

Regional Centre for Biotechnology (RCB), Faridabad 121 001, India. Electronic address: s.chandru@rcb.res.in.

Shubhra Agarwal (S)

Regional Centre for Biotechnology (RCB), Faridabad 121 001, India. Electronic address: shubhra.agarwal@rcb.res.in.

Jia Wang (J)

AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305 8565, Japan. Electronic address: wang-jia0819@aist.go.jp.

Huayue Zhang (H)

AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305 8565, Japan. Electronic address: zhang-huayue@aist.go.jp.

Ashish Kaul (A)

AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305 8565, Japan. Electronic address: ashish-kaul@aist.go.jp.

Rajkumar Singh Kalra (RS)

AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305 8565, Japan. Electronic address: rajkumar-singh@oist.jp.

Sunil C Kaul (SC)

AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305 8565, Japan. Electronic address: s-kaul@aist.go.jp.

Sudhanshu Vrati (S)

Regional Centre for Biotechnology (RCB), Faridabad 121 001, India. Electronic address: vrati@rcb.res.in.

Durai Sundar (D)

DAILAB, Department of Biochemical Engineering & Biotechnology, Indian Institute of Technology (IIT) Delhi, Hauz Khas, New Delhi 110 016, India. Electronic address: sundar@dbeb.iitd.ac.in.

Renu Wadhwa (R)

AIST-INDIA DAILAB, DBT-AIST International Center for Translational & Environmental Research (DAICENTER), National Institute of Advanced Industrial Science & Technology (AIST), Tsukuba 305 8565, Japan. Electronic address: renu-wadhwa@aist.go.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH